Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 27/100

Termination Rate

0.0%

0 terminated out of 9 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

7Total

Not Applicable (3)

P 1 (1)

P 2 (2)

P 3 (1)

Trial Status

Completed5

Recruiting2

Active Not Recruiting2

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (9)

Showing 9 of 9 trials

NCT07286370Phase 2RecruitingPrimary

A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella Disease and Typhoid Fever in Infants

NCT05480800Phase 1CompletedPrimary

A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella and Typhoid Fever

NCT05870150Not ApplicableActive Not RecruitingPrimary

Challenge Non-Typhoidal Salmonella (CHANTS) Study

NCT04694235Not ApplicableActive Not Recruiting

Egg Intervention During Pregnancy in Indonesia

NCT06213506Phase 2RecruitingPrimary

A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nontyphoidal Salmonella in Adults, Children, and Infants

NCT02689193Completed

IDIS Project Work Package 2: Establishing a Biobank at ITM and Collaborating Centres

NCT03073707CompletedPrimary

Reservoir of Invasive Salmonellosis in Children, DRC

NCT01608815Phase 3CompletedPrimary

Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects

NCT00002052Not ApplicableCompleted

Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients

Showing all 9 trials